Literature DB >> 35433358

Pulmonary thromboendarterectomy in chronic pulmonary disease-the Royal Papworth Hospital experience.

David P Jenkins1.   

Abstract

Entities:  

Year:  2022        PMID： 35433358      PMCID： PMC9012200          DOI： 10.21037/acs-2021-pte-24

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN： 2225-319X


× No keyword cloud information.
  5 in total

1.  Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease.

Authors:  Stefan Guth; Christoph B Wiedenroth; Andreas Rieth; Manuel J Richter; Ekkehard Gruenig; Hossein Ardeshir Ghofrani; Matthias Arlt; Christoph Liebetrau; Diethard Prüfer; Andreas Rolf; Christian W Hamm; Eckhard Mayer
Journal:  Eur Respir J       Date:  2018-09-17       Impact factor: 16.671

2.  Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease.

Authors:  Dolores Taboada; Joanna Pepke-Zaba; David P Jenkins; Marius Berman; Carmen M Treacy; John E Cannon; Mark Toshner; John J Dunning; Choo Ng; Steven S Tsui; Karen K Sheares
Journal:  Eur Respir J       Date:  2014-09-18       Impact factor: 16.671

3.  Pulmonary thromboendarterectomy-the Royal Papworth experience.

Authors:  David P Jenkins; Steven S Tsui; John Taghavi; Pradeep Kaul; Jason Ali; Choo Ng
Journal:  Ann Cardiothorac Surg       Date:  2022-03

4.  Case report: Subjective loss of performance after pulmonary embolism in an athlete- beyond normal values.

Authors:  Daniel Dumitrescu; Felix Gerhardt; Thomas Viethen; Matthias Schmidt; Eckhard Mayer; Stephan Rosenkranz
Journal:  BMC Pulm Med       Date:  2016-01-28       Impact factor: 3.317

5.  Pulmonary endarterectomy for patients with chronic thromboembolic disease.

Authors:  Şehnaz Olgun Yıldızeli; Alper Kepez; Serpil Taş; Mehmed Yanartaş; Ali Fuad Durusoy; Atakan Erkılınç; Bülent Mutlu; Cihangir Kaymaz; Hasan Sunar; Bedrettin Yıldızeli
Journal:  Anatol J Cardiol       Date:  2018-04       Impact factor: 1.596
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.